According to the new market research report " HLA
Typing for Transplant Market by Technology (SSO-PCR, SSP-PCR, NGS, Sanger’s
Sequencing), Products & Services (Instruments, Reagents, Software),
Application (Diagnostics, Research), End User (Hospitals, Academia, Diagnostic
Center) - Forecast to 2021", published by MarketsandMarkets™,The global
HLA typing for transplant market is projected to reach USD 753.9 Million by
2021 from USD 535.0 Million in 2016, at a CAGR of 7.1% from 2016 to 2021.
Don’t miss out on
business opportunities in Transplant
Diagnostics Market
Browse and in-depth
TOC on "Transplant Diagnostics Market"
60 - Figures
203 - Pages
Get Free 10%
customization: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=96374742
Market growth can be
attributed to factors such as the rising number of solid organ, soft tissue,
and stem cell transplantations; technological advancements in the field of organ
transplantation; increased funding, research grants, and public-private
investments; technological shift from serological assays to gene-based HLA
profiling; and improving healthcare infrastructure across developing countries.
To know about the
assumptions considered for the study, download
the pdf brochure
Scope of the Report
This research report categorizes the HLA typing for
transplant market into the following segments and sub segments:
HLA Typing for
Transplant Market, By Technology
·
Non-Molecular
Assay
§
Serological Assay
§
Mixed Lymphocyte Culture Assay (MLC Assay)
·
Molecular
Assay
§
PCR-based
o
Sequence specific primer-PCR (SSP-PCR)
o
Sequence specific oligonucleotide-PCR (SSO-PCR)
·
Sequencing-based
§
Next Generation Sequencing
§
Sanger’s Sequencing
Please click here to
get the global report of Transplant
Diagnostics Market by Technology (PCR, SSO-PCR, SSP-PCR, NGS, Sanger’s
Sequencing, Microarray), Products & Services (Instruments, Reagents),
Application (Blood Profiling, Infectious Disease Testing), End User (Hospitals)
- Global forecast 2021
The global HLA typing for transplant market is projected to
reach USD 753.9 Million by 2021 from USD 535.0 Million in 2016, growing at a
CAGR of 7.1% from 2016 to 2021. Market growth can be attributed to factors such
as the rising number of solid organ, soft tissue, and stem cell
transplantations; technological advancements in the field of organ
transplantations; and increased funding, research grants, and public-private
investments. However, the high device costs associated with NGS and PCR-based
devices and limited medical reimbursements for organ donation and
transplantation procedures restrain the optimal growth of the HLA typing for
transplant market.
To speak to our
analyst for a discussion on the above findings,
click Speak to Analyst
No comments:
Post a Comment